93 related articles for article (PubMed ID: 25648557)
1. PYK2 sustains endosomal-derived receptor signalling and enhances epithelial-to-mesenchymal transition.
Verma N; Keinan O; Selitrennik M; Karn T; Filipits M; Lev S
Nat Commun; 2015 Feb; 6():6064. PubMed ID: 25648557
[TBL] [Abstract][Full Text] [Related]
2. PYK2 integrates growth factor and cytokine receptors signaling and potentiates breast cancer invasion via a positive feedback loop.
Selitrennik M; Lev S
Oncotarget; 2015 Sep; 6(26):22214-26. PubMed ID: 26084289
[TBL] [Abstract][Full Text] [Related]
3. Aberrantly expressed Fra-1 by IL-6/STAT3 transactivation promotes colorectal cancer aggressiveness through epithelial-mesenchymal transition.
Liu H; Ren G; Wang T; Chen Y; Gong C; Bai Y; Wang B; Qi H; Shen J; Zhu L; Qian C; Lai M; Shao J
Carcinogenesis; 2015 Apr; 36(4):459-68. PubMed ID: 25750173
[TBL] [Abstract][Full Text] [Related]
4. Epithelial to mesenchymal transition promotes breast cancer progression via a fibronectin-dependent STAT3 signaling pathway.
Balanis N; Wendt MK; Schiemann BJ; Wang Z; Schiemann WP; Carlin CR
J Biol Chem; 2013 Jun; 288(25):17954-67. PubMed ID: 23653350
[TBL] [Abstract][Full Text] [Related]
5. Systems modelling of the EGFR-PYK2-c-Met interaction network predicts and prioritizes synergistic drug combinations for triple-negative breast cancer.
Shin SY; Müller AK; Verma N; Lev S; Nguyen LK
PLoS Comput Biol; 2018 Jun; 14(6):e1006192. PubMed ID: 29920512
[TBL] [Abstract][Full Text] [Related]
6. Proline-rich tyrosine kinase 2 (Pyk2) promotes cell motility of hepatocellular carcinoma through induction of epithelial to mesenchymal transition.
Sun CK; Ng KT; Lim ZX; Cheng Q; Lo CM; Poon RT; Man K; Wong N; Fan ST
PLoS One; 2011 Apr; 6(4):e18878. PubMed ID: 21533080
[TBL] [Abstract][Full Text] [Related]
7. Different modes and qualities of tyrosine phosphorylation of Fak and Pyk2 during epithelial-mesenchymal transdifferentiation and cell migration: analysis of specific phosphorylation events using site-directed antibodies.
Nakamura K; Yano H; Schaefer E; Sabe H
Oncogene; 2001 May; 20(21):2626-35. PubMed ID: 11420674
[TBL] [Abstract][Full Text] [Related]
8. PYK2, a hub of signaling networks in breast cancer progression.
Gil-Henn H; Girault JA; Lev S
Trends Cell Biol; 2024 Apr; 34(4):312-326. PubMed ID: 37586982
[TBL] [Abstract][Full Text] [Related]
9. The AXL-PYK2-PKCα axis as a nexus of stemness circuits in TNBC.
Khera L; Vinik Y; Maina F; Lev S
Life Sci Alliance; 2021 Jun; 4(6):. PubMed ID: 33785524
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-6-induced epithelial-mesenchymal transition through signal transducer and activator of transcription 3 in human cervical carcinoma.
Miao JW; Liu LJ; Huang J
Int J Oncol; 2014 Jul; 45(1):165-76. PubMed ID: 24806843
[TBL] [Abstract][Full Text] [Related]
11. Testican-1-mediated epithelial-mesenchymal transition signaling confers acquired resistance to lapatinib in HER2-positive gastric cancer.
Kim HP; Han SW; Song SH; Jeong EG; Lee MY; Hwang D; Im SA; Bang YJ; Kim TY
Oncogene; 2014 Jun; 33(25):3334-41. PubMed ID: 23873022
[TBL] [Abstract][Full Text] [Related]
12. Focal adhesion kinase-related proline-rich tyrosine kinase 2 and focal adhesion kinase are co-overexpressed in early-stage and invasive ErbB-2-positive breast cancer and cooperate for breast cancer cell tumorigenesis and invasiveness.
Behmoaram E; Bijian K; Jie S; Xu Y; Darnel A; Bismar TA; Alaoui-Jamali MA
Am J Pathol; 2008 Nov; 173(5):1540-50. PubMed ID: 18832579
[TBL] [Abstract][Full Text] [Related]
13. Pyk2 and Src mediate signaling to CCL18-induced breast cancer metastasis.
Li HY; Cui XY; Wu W; Yu FY; Yao HR; Liu Q; Song EW; Chen JQ
J Cell Biochem; 2014 Mar; 115(3):596-603. PubMed ID: 24142406
[TBL] [Abstract][Full Text] [Related]
14. Down-Regulation of DDR1 Induces Apoptosis and Inhibits EMT through Phosphorylation of Pyk2/MKK7 in DU-145 and Lncap-FGC Prostate Cancer Cell Lines.
Azizi R; Fallahian F; Aghaei M; Salemi Z
Anticancer Agents Med Chem; 2020; 20(8):1009-1016. PubMed ID: 32275493
[TBL] [Abstract][Full Text] [Related]
15. Extracellular signal-regulated kinase and Akt activation play a critical role in the process of hepatocyte growth factor-induced epithelial-mesenchymal transition.
Tanahashi T; Osada S; Yamada A; Kato J; Yawata K; Mori R; Imai H; Sasaki Y; Saito S; Tanaka Y; Nonaka K; Yoshida K
Int J Oncol; 2013 Feb; 42(2):556-64. PubMed ID: 23229794
[TBL] [Abstract][Full Text] [Related]
16. ACK1 promotes gastric cancer epithelial-mesenchymal transition and metastasis through AKT-POU2F1-ECD signalling.
Xu SH; Huang JZ; Xu ML; Yu G; Yin XF; Chen D; Yan GR
J Pathol; 2015 Jun; 236(2):175-85. PubMed ID: 25678401
[TBL] [Abstract][Full Text] [Related]
17. Epidermal growth factor-induced ovarian carcinoma cell migration is associated with JAK2/STAT3 signals and changes in the abundance and localization of alpha6beta1 integrin.
Colomiere M; Findlay J; Ackland L; Ahmed N
Int J Biochem Cell Biol; 2009 May; 41(5):1034-45. PubMed ID: 18930836
[TBL] [Abstract][Full Text] [Related]
18. Met endosomal signalling: in the right place, at the right time.
Barrow-McGee R; Kermorgant S
Int J Biochem Cell Biol; 2014 Apr; 49():69-74. PubMed ID: 24440758
[TBL] [Abstract][Full Text] [Related]
19. Regulation of EMT by STAT3 in gastrointestinal cancer (Review).
Li B; Huang C
Int J Oncol; 2017 Mar; 50(3):753-767. PubMed ID: 28098855
[TBL] [Abstract][Full Text] [Related]
20. Tumor suppressor SCUBE2 inhibits breast-cancer cell migration and invasion through the reversal of epithelial-mesenchymal transition.
Lin YC; Lee YC; Li LH; Cheng CJ; Yang RB
J Cell Sci; 2014 Jan; 127(Pt 1):85-100. PubMed ID: 24213532
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]